Page, D. B., Elkhanany, A., Samiian, L., Elayoubi, J., Rahman, R. L., Dias, E., Santillan, A. A., Brown, E. A., Gold, L. P., Matt-Amaral, L. B., Dekhne, N., Lesnikoski, B., Hampton, R., Conter, H. J., Uygun, S., Stivers, N., Menicucci, A., Audeh, W., O'Shaughnessy, J. (2026). Integration of molecular subtyping and immune profiling to predict pathologic complete response in HER2+ breast cancer treated with neoadjuvant dual HER2 therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.621